Healio (5/4, Hornick) reports, “Patients with asthma and neuropathic/chronic pain using gabapentinoids vs. tricyclic antidepressants or serotonin norepinephrine reuptake inhibitors had an elevated risk for asthma exacerbations, according to” research. Investigators came to this conclusion after conducting an “analysis of gabapentinoids vs. TCAs” that “included 171,393 patients starting gabapentinoid use and 5,916 patients starting TCA use, and” an “analysis of gabapentinoids vs. SNRIs” that “included 189,055 patients newly using gabapentinoids and 19,800 patients newly using SNRIs.” The findings were published in Thorax.
Related Links:
— “Gabapentinoid use raises risk for asthma exacerbations,”Isabella Hornick, Healio, May 4, 2026